Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms.
about
Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeuticsNeural stem/progenitor cells in Alzheimer's diseaseNeuroprotective Effects Against POCD by Photobiomodulation: Evidence from Assembly/Disassembly of the CytoskeletonRole of pro-inflammatory cytokines released from microglia in Alzheimer's diseaseMicroglial cell dysregulation in brain aging and neurodegenerationDiverse molecular targets for therapeutic strategies in Alzheimer's diseaseBrain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid systemTherapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseAccumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neuronsAlzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and GammaBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseIn vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's diseaseRANTES release contributes to the protective action of PACAP38 against sodium nitroprusside in cortical neuronsCeramide-mediated insulin resistance and impairment of cognitive-motor functionsEarly and progressive deficit of neuronal activity patterns in a model of local amyloid pathology in mouse prefrontal cortexCD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation.RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.Alzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brainProtective role of S-nitrosoglutathione (GSNO) against cognitive impairment in rat model of chronic cerebral hypoperfusion.Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections.Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw.16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer's Post-Mortem BrainFlexibilide obtained from cultured soft coral has anti-neuroinflammatory and analgesic effects through the upregulation of spinal transforming growth factor-β1 in neuropathic ratsDegenerative alterations in noradrenergic neurons of the locus coeruleus in Alzheimer's diseaseThe vascular contribution to Alzheimer's disease.Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseasesInduction of amyloid-β(1-42) in the retina and optic nerve head of chronic ocular hypertensive monkeysReliable disease biomarkers characterizing and identifying electrohypersensitivity and multiple chemical sensitivity as two etiopathogenic aspects of a unique pathological disorder.Mediterranean diet, Alzheimer disease, and vascular mediationMediterranean diet and essential tremor. A case-control study.Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target.Expression and localization of prostaglandin transporter in Alzheimer disease brains and age-matched controlsMassive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition.Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.Determination of spatial and temporal distribution of microglia by 230nm-high-resolution, high-throughput automated analysis reveals different amyloid plaque populations in an APP/PS1 mouse model of Alzheimer's disease.The inhalation anesthetic isoflurane increases levels of proinflammatory TNF-α, IL-6, and IL-1β.Selective protection of the cerebellum against intracerebroventricular LPS is mediated by local melatonin synthesisThe microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's diseaseExpression of glia maturation factor in neuropathological lesions of Alzheimer's diseaseMechanisms of ceramide-mediated neurodegeneration.
P2860
Q24685475-84E8E3F2-656B-4746-80FD-7AE649A30E4DQ26738352-F6AE8564-626E-4187-9D9C-EDAE50018B43Q26768713-CFB2E5F0-E263-43AF-A169-387F5D752C78Q26799870-8012CB0E-541B-4641-8A57-54A463A0CDBAQ26800212-AA833733-2449-491C-AE2B-D34AB982714EQ26827193-9B7903F7-D713-4463-9B81-BFD1BB2CE6E0Q26865295-2BBE484C-5A89-4F36-8274-CCF879C72A6FQ27021700-0F66939A-4253-4290-959D-E24D7F1BB571Q27301082-6C056D0B-F5F0-4B62-8539-69173B320196Q28075617-FB672C65-1524-46AD-9E14-34B38EDF6189Q28259585-DAE26D37-BC94-4BE0-8AB6-9C044BBB6BE4Q28274003-E92AE8CD-70D5-4F8E-8AAD-EB26A8439513Q28567751-91385410-677D-4B08-9526-061A463C0EF5Q30478907-A74AFF3D-9EA7-40D2-B1FD-CA944D306594Q30836664-41828166-A931-4FE8-869B-675D57827B97Q33334431-81C129F5-C7E2-4979-9519-932083E252EAQ33578739-6EEC47B5-4883-4416-BD31-A7EF3B7E51EBQ33589491-57B46F81-FDAC-4177-8D9C-ED7F3B612985Q33692827-E477661F-B478-432C-A73B-C209B15DF313Q33710078-D7AB2067-32AE-4B78-A0D1-2B5075F6B027Q33793891-2C1A016B-3EB2-4988-B513-4E3EF271F9D0Q33813209-A69FAD1D-BF45-4673-95C3-2464F337634FQ33963470-03723DB6-4E88-438A-9512-C2A70A38C2D4Q34095163-A0F898DA-5765-4129-BD69-1A96DC47A3EBQ34178526-480BB5D5-F229-4B09-BB68-82137F3A5465Q34288447-3E3198DD-E82A-47E0-8855-39B07F461393Q34483981-7C0000C5-1D21-4B01-AF7B-F074DCB1FBF4Q34503321-E8774950-4569-4C82-97A4-B55F5C136950Q34510165-F413DDC8-1ACE-4F14-9668-43D9C35681E7Q34536096-B01F8AD1-ED1A-47D5-A821-475B1C37CCE8Q34680801-09FF3393-721A-4E52-9664-5F88DF1FBF92Q34763280-2FB82CD0-53BC-4684-BD6E-EAD4272E4A76Q34878224-456D5AFB-E8CA-40F0-AE87-CB688569BE2AQ34898890-1EC9E7D1-8B4C-4C26-8F8F-226698EE0872Q35050837-F133627B-D99E-4CA4-89BA-D5F5ED9E2EBBQ35051137-0E6C093A-8A27-4598-8516-5F8EA6AB66E4Q35123174-6405CB29-CB2F-45BC-98F0-8CAF53C0A911Q35132234-5F8C6025-F982-4AAD-9273-766863847483Q35791396-24CF1149-843A-4501-83D0-C8091320D11DQ35997878-FF4BCE4A-2948-4B39-A0B1-D5CC8B378C85
P2860
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms.
@ast
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms.
@en
type
label
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms.
@ast
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms.
@en
prefLabel
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms.
@ast
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms.
@en
P1476
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms.
@en
P2093
Magdalena Sastre
Michael T Heneka
P304
P356
10.1016/J.IJDEVNEU.2005.11.014
P577
2006-02-10T00:00:00Z